Researchers
from Case Western Reserve University have discovered how byproducts in the form
of small fatty acids from two bacteria prevalent in gum disease incite the
growth of deadly Kaposi's sarcoma-related (KS) lesions and tumors in the mouth.
The
discovery could lead to early saliva testing for the bacteria, which, if found,
could be treated and monitored for signs of cancer and before it develops into
a malignancy, researchers say.
"These
new findings provide one of the first looks at how the periodontal bacteria
create a unique microenvironment in the oral cavity that contributes to the
replication the Kaposi's sarcoma Herpesvirus (KSHV) and development of
KS," said Fengchun Ye, the study's lead investigator from Case Western
Reserve School of Dental Medicine's Department of Biological Sciences.
The
discovery is described in The Journal of Virology article, "Short Chain
Fatty Acids from Periodontal Pathogens Suppress HDACs, EZH2, and SUV39H1 to
Promote Kaposi's Sarcoma-Associated Herpesvirus Replication."
The
research focuses on how the bacteria, Porphyromonas gingivalis (Pg) and
Fusobacterium nucleatum (Fn), which are associated with gum disease, contribute
to cancer formation.
Ye
said high levels of these bacteria are found in the saliva of people with
periodontal disease, and at lower levels in those with good oral health --
further evidence of the link between oral and overall physical health.
KS
impacts a significant number of people with HIV, whose immune systems lack the
ability to fight off the herpesvirus and other infections, he said.
"These
individual are susceptible to the cancer," Ye said.
KS
first appears as lesions on the surface of the mouth that, if not removed, can
grow into malignant tumors. Survival rates are higher when detected and treated
early in the lesion state than when a malignancy develops.
Also
at risk are people with compromised immune systems: people on medications to
suppress rejection of transplants, cancer patients on chemotherapies and the
elderly population whose immune systems naturally weaken with age.
The
researchers wanted to learn why most people never develop this form of cancer
and what it is that protects them.
The
researchers recruited 21 patients, dividing them into two groups. All
participants were given standard gum-disease tests.
The
first group of 11 participants had an average age of 50 and had severe chronic
gum disease. The second group of 10 participants, whose average age was about
26, had healthy gums, practiced good oral health and showed no signs of
bleeding or tooth loss from periodontal disease.
The
researchers also studied a saliva sample from each. Part of the saliva sample
was separated into its components using a spinning centrifuge. The remaining
saliva was used for DNA testing to track and identify bacteria present, and at
what levels.
The
researchers were interested in Pg's and Fn's byproducts of lipopolysaccharide,
fimbriae, proteinases and at least five different short-chain fatty acids
(SCFA): butyric acid, isobutryic acid, isovaleric acid, propionic acid and
acetic acid.
After
initially testing the byproducts, the researchers suspected that the fatty
acids were involved in replicating KSHV. The researchers cleansed the fatty
acids and then introduced them to cells with quiescent KSHV virus in a petri
dish for monitoring the virus' reaction.
After
introducing SCFA, the virus began to replicate. But the researchers saw that,
while the fatty acids allowed the virus to multiple, the process also set in
motion a cascade of actions that also inhibited molecules in the body's immune
system from stopping the growth of KSHV.
"The
most important thing to come out of this study is that we believe periodontal
disease is a risk factor for Kaposi sarcoma tumor in HIV patients," Ye
said.
With
that knowledge, Ye said those with HIV must be informed about the importance of
good oral health and the possible consequences of overlooking that area.
No comments:
Post a Comment